BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akhiani AA, Stensson A, Schön K, Lycke NY. IgA Antibodies Impair Resistance against Helicobacter pylori Infection: Studies on Immune Evasion in IL-10-Deficient Mice. J Immunol 2005;174:8144-53. [DOI: 10.4049/jimmunol.174.12.8144] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Tan Z, Liu W, Liu H, Li C, Zhang Y, Meng X, Tang T, Xi T, Xing Y. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection. European Journal of Pharmaceutics and Biopharmaceutics 2017;111:33-43. [DOI: 10.1016/j.ejpb.2016.11.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
2 Wolfe DN, Kirimanjeswara GS, Goebel EM, Harvill ET. Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infect Immun 2007;75:4416-22. [PMID: 17591791 DOI: 10.1128/IAI.00412-07] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
3 Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter. 2007;12:89-102. [PMID: 17309745 DOI: 10.1111/j.1523-5378.2007.00478.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
4 Chmiela M, Michetti P. Inflammation, immunity, vaccines for Helicobacter infection. Helicobacter. 2006;11 Suppl 1:21-26. [PMID: 16925607 DOI: 10.1111/j.1478-405x.2006.00422.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
5 Hickey DK, Aldwell FE, Tan ZY, Bao S, Beagley KW. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Vaccine 2009;27:6983-90. [DOI: 10.1016/j.vaccine.2009.09.078] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
6 Spencer J, Boursier L, Edgeworth JD. IgA Plasma Cell Development. In: Kaetzel CS, editor. Mucosal Immune Defense: Immunoglobulin A. Boston: Springer US; 2007. pp. 25-42. [DOI: 10.1007/978-0-387-72232-0_2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Neumann L, Mueller M, Moos V, Heller F, Meyer TF, Loddenkemper C, Bojarski C, Fehlings M, Doerner T, Allers K, Aebischer T, Ignatius R, Schneider T. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol 2016;197:1801-8. [PMID: 27456483 DOI: 10.4049/jimmunol.1501330] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
8 Gorrell RJ, Robins-Browne RM. Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infect Immun 2009;77:5116-29. [PMID: 19737910 DOI: 10.1128/IAI.00547-09] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Chen J, Lin L, Li N, She F. Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids. Microbiol Immunol. 2012;56:85-92. [PMID: 22150716 DOI: 10.1111/j.1348-0421.2011.00409.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
10 Mcloughlin K, Schluter J, Rakoff-nahoum S, Smith A, Foster K. Host Selection of Microbiota via Differential Adhesion. Cell Host & Microbe 2016;19:550-9. [DOI: 10.1016/j.chom.2016.02.021] [Cited by in Crossref: 102] [Cited by in F6Publishing: 80] [Article Influence: 17.0] [Reference Citation Analysis]
11 Inoue K, Shiota S, Yamada K, Gotoh K, Suganuma M, Fujioka T, Ahmed K, Iha H, Nishizono A. Evaluation of a New Tumor Necrosis Factor-α-Inducing Membrane Protein of Helicobacter pylori as a Prophylactic Vaccine Antigen: H. pylori Tipα Vaccine. Helicobacter 2009;14:487-95. [DOI: 10.1111/j.1523-5378.2009.00713.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
12 Whary MT, Taylor NS, Feng Y, Ge Z, Muthupalani S, Versalovic J, Fox JG. Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice. Immunology 2011;133:165-78. [PMID: 21426337 DOI: 10.1111/j.1365-2567.2011.03423.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
13 Worthley DL, Mullighan CG, Dean MM, Gordon DL, Phillips P, Heatley S, Young GP, Bardy PG. Mannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivity. Eur J Gastroenterol Hepatol 2007;19:147-52. [PMID: 17273000 DOI: 10.1097/MEG.0b013e3280106729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Peek RM Jr, Fiske C, Wilson KT. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev. 2010;90:831-858. [PMID: 20664074 DOI: 10.1152/physrev.00039.2009] [Cited by in Crossref: 133] [Cited by in F6Publishing: 128] [Article Influence: 11.1] [Reference Citation Analysis]
15 Gorrell RJ, Wijburg OL, Pedersen JS, Walduck AK, Kwok T, Strugnell RA, Robins-Browne RM. Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori. Infect Immun 2013;81:3880-93. [PMID: 23918779 DOI: 10.1128/IAI.01424-12] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
16 Robinson K, Argent RH, Atherton JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21:237-259. [PMID: 17382275 DOI: 10.1016/j.bpg.2007.01.001] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 7.3] [Reference Citation Analysis]
17 Attaran B, Falsafi T, Moghaddam AN. Study of biofilm formation in C57Bl/6J mice by clinical isolates of Helicobacter pylori. Saudi J Gastroenterol. 2016;22:161-168. [PMID: 26997224 DOI: 10.4103/1319-3767.178529] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
18 Del Giudice G, Malfertheiner P, Rappuoli R. Development of vaccines against Helicobacter pylori. Expert Rev Vaccines. 2009;8:1037-1049. [PMID: 19627186 DOI: 10.1586/erv.09.62] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
19 Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23:713-739. [PMID: 20930071 DOI: 10.1128/cmr.00011-10] [Cited by in Crossref: 680] [Cited by in F6Publishing: 383] [Article Influence: 56.7] [Reference Citation Analysis]
20 Taylor JM, Ziman ME, Fong J, Solnick JV, Vajdy M. Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. Infect Immun 2007;75:3462-9. [PMID: 17502399 DOI: 10.1128/IAI.01470-06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
21 Velin D, Bachmann D, Bouzourene H, Michetti P. Reduction of Helicobacter infection in IL-10-/- mice is dependent on CD4+ T cells but not on mast cells. Helicobacter 2008;13:361-9. [PMID: 19250511 DOI: 10.1111/j.1523-5378.2008.00614.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
22 Aebischer T, Meyer TF, Andersen LP. Inflammation, immunity, and vaccines for Helicobacter. Helicobacter. 2010;15 Suppl 1:21-28. [PMID: 21054649 DOI: 10.1111/j.1523-5378.2010.00777.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
23 Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology. 2007;133:288-308. [PMID: 17631150 DOI: 10.1053/j.gastro.2007.05.008] [Cited by in Crossref: 167] [Cited by in F6Publishing: 164] [Article Influence: 11.1] [Reference Citation Analysis]
24 Freeman AF, Holland SM. Persistent bacterial infections and primary immune disorders. Curr Opin Microbiol. 2007;10:70-75. [PMID: 17208513 DOI: 10.1016/j.mib.2006.11.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
25 Allison CC, Ferrero RL. Role of virulence factors and host cell signaling in the recognition of Helicobacter pylori and the generation of immune responses. Future Microbiol 2010;5:1233-55. [PMID: 20722601 DOI: 10.2217/fmb.10.84] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
26 Park J, Park S, Hong K, Han Y, Jang S, Kim E, Hahm K. Special Licorice Extracts Containing Lowered Glycyrrhizin and Enhanced Licochalcone A Prevented Helicobacter pylori -Initiated, Salt Diet-Promoted Gastric Tumorigenesis. Helicobacter 2014;19:221-36. [DOI: 10.1111/hel.12121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
27 Reyes VE, Peniche AG. Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion. Curr Top Microbiol Immunol 2019;421:229-65. [PMID: 31123892 DOI: 10.1007/978-3-030-15138-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
28 Müller A, Oertli M, Arnold IC. H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell Commun Signal. 2011;9:25. [PMID: 22044597 DOI: 10.1186/1478-811x-9-25] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
29 Ghasemian Safaei H, Faghri J, Moghim S, Nasr Esfahani B, Fazeli H, Makvandi M, Adib M, Rashidi N. Production of IFN-γ and IL-4 Against Intact Catalase and Constructed Catalase Epitopes of Helicobacter pylori From T-Cells. Jundishapur J Microbiol 2015;8:e24697. [PMID: 26862387 DOI: 10.5812/jjm.24697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
30 Wehrens A, Aebischer T, Meyer TF, Walduck AK. Leptin receptor signaling is required for vaccine-induced protection against Helicobacter pylori. Helicobacter. 2008;13:94-102. [PMID: 18321299 DOI: 10.1111/j.1523-5378.2008.00591.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
31 Dakkak BM, Imam Y, Ahmed K, Saleh AO, Soliman D, Alanzi M, Yassin MA, Mohamed S. Selective Immunoglobulin A Deficiency, Helicobacter pylori Infection, and Strongyloidiasis in a Patient with Adenocarcinoma of the Stomach. Case Rep Oncol 2020;13:1325-9. [PMID: 33250749 DOI: 10.1159/000511066] [Reference Citation Analysis]